Wnting out ocular neovascularization: using nanoparticle delivery of very-low density lipoprotein receptor extracellular domain as Wnt pathway inhibitor in the retina

Arterioscler Thromb Vasc Biol. 2015 May;35(5):1046-7. doi: 10.1161/ATVBAHA.115.305395.

Authors

Julia V Busik¹, Maria B Grant²

Affiliations

¹ From the Department of Physiology, Michigan State University, East Lansing (J.V.B.); and Departments of Ophthalmology and Cellular and Integrative Physiology, Indiana University, Indianapolis (M.B.G.). busik@msu.edu.
² From the Department of Physiology, Michigan State University, East Lansing (J.V.B.); and Departments of Ophthalmology and Cellular and Integrative Physiology, Indiana University, Indianapolis (M.B.G.).

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Animals
Cornea / blood supply*
Corneal Neovascularization / prevention & control*
Humans
Lactic Acid / chemistry*
Nanoparticles*
Polyglycolic Acid / chemistry*
Receptors, LDL / metabolism*
Retinal Neovascularization / prevention & control*
Retinal Vessels / metabolism*
Transfection / methods*
Wnt Signaling Pathway*
Wnt3A Protein / metabolism*

Substances

Receptors, LDL
Wnt3A Protein
Polyglycolic Acid
Lactic Acid

Grants and funding